$Cassava Sciences (SAVA.US)$ This stock should be in triple ...
$Cassava Sciences(SAVA.US$ This stock should be in triple digits by now especially with 90 % rate of patients wanting to stay on Phase 3 Trials and the recent statement " Discussion with FDA to finalize a statistical analysis plan (SAP) to undertake as efficacy data collected." The stock price instantly being shorted down to under $23 is a disgusting manipulation and cheating with fake synthetic shares by shorts. The SEC , DOJ and media should not be allowed to continue to let this going on like this and we need to bring awareness to this however we can because it's criminal what the shorts have done and not being held accountable .
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
